The regulatory landscape for pharmaceutical and medical device companies is not static. State boards of pharmacy, departments of health, controlled substance authorities, and other regulatory...
Insights
Puerto Rico’s GLP-1 Registration Landscape: Why FDA Approval Matters for Peptide Products
The demand for GLP-1 medications has transformed the pharmaceutical marketplace. Manufacturers, distributors, compounding pharmacies, telehealth organizations, and other healthcare businesses...
Why Proactive State Licensing Is Becoming a Competitive Advantage for CMOs and CDMOs
For years, many contract manufacturing organizations (CMOs) and contract drug manufacturing organizations (CDMOs) viewed state pharmaceutical licensing as a reactive process. If they were not...
The Hidden DSCSA Compliance Risk: Why Verifying Incoming Trading Partners Matters Just as Much as Outgoing Shipments
For pharmaceutical manufacturers, wholesale distributors, repackagers, third-party logistics providers, and dispensers, the Drug Supply Chain Security Act (DSCSA) has fundamentally changed how...
Your License Portfolio Is Only as Strong as the Assessment Behind It
When pharmaceutical companies evaluate their state licensing compliance, the conversation often begins with a simple question: "Do we have all the licenses we need?" Unfortunately, that question...
Beyond the Application: Building a Successful Wholesale Distributor Licensing Strategy
Expanding pharmaceutical distribution capabilities is an exciting milestone for any organization. Whether launching a new wholesale distribution business, expanding into additional markets, or...
Expanding into Puerto Rico? Here’s What Pharmaceutical Companies Need to Know Before Entering the Market
For pharmaceutical manufacturers, wholesale distributors, virtual manufacturers, and other regulated pharma organizations, Puerto Rico represents an important extension of the U.S. marketplace....
Employee Screening for Controlled Substance Access: The Compliance Requirement Too Many Companies Take for Granted
In highly regulated pharmaceutical operations, companies invest significant time and resources into physical security, inventory controls, DEA registrations, and state licensing requirements....
Why Every Pharmaceutical Company Needs More Than One Designated Representative
Imagine receiving notice that your facility's Designated Representative has resigned effective immediately. At first glance, it may seem like a standard personnel issue. Someone leaves, you...
FDA Registration Is Not a State Licensing Strategy: What Medical Device Companies Need to Know
For many medical device companies, regulatory compliance begins with the FDA. Establishment registration is completed. Device listings are maintained. Quality systems are implemented. From a...